novavax vaccine - Search News

Order byBest matchMost fresh

FDA approves Novavax COVID-19 vaccine

Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine

(Reuters) -Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 vaccine from the U.S. health regulator, albeit with new conditions. The U.

· 2d · on MSN

After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk

AARP · 9h

Third COVID Vaccine Gets Approved for Adults 65 and Over

· 11h

RFK Jr. pledged not to upend US vaccine system, but big changes are underway

Robert F. Kennedy Jr. clinched the political support needed to become the nation’s top health official by pledging to work within the decades-old federal system for approval and use of vaccines.

· 1d

FDA approves Novavax COVID-19 shot but with unusual restrictions

· 17h

Novavax jumps as FDA clears COVID-19 vaccine

BioPharma Dive13h

Novavax’s COVID vaccine gets FDA approval, but with limits

While the clearance is only for use in certain groups, Novavax’s long-awaited OK is still seen by analysts as a “win” for the company.

JPMorgan Maintains Underweight Rating on Novavax (NVAX) Stock Despite Positive News

JPMorgan analyst Eric Joseph reaffirmed an Underweight rating for Novavax Inc. (NASDAQ:NVAX) with a price target of $7. This comes after the Food and Drug Administration (FDA) approved the company’s COVID-19 vaccine,

Devdiscourse2d

Global Health Alert: From Bird Flu in Brazil to Promising HIV Vaccine Trials

Health-related headlines include Mexico's suspension of poultry imports from Brazil due to bird flu, promising results from new HIV vaccine trials, and the FDA's conditional approval of Novavax's COVID-19 vaccine.

Explore more

COVID-19

Food and Drug Administration